HCW Biologics (HCWB) Stock Price, Quote, News & History

HCW Biologics Inc (HCWB) Stock Price, Quote, News & History

HCWBNASDAQ

Trade with Public

$0.4070

0.06117.63%

At close: Apr 14, 5:00 PM EST

$0.4087

0.062718.12%

Pre-Market: 8:28 AM EST

Key Statistics

Open

$0.41

Volume / Avg.

108.25K / 8.25M

Day Range

- - -

52 Wk Range

0.25 - 17.80

Market Cap

$1.44M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

3.61%

Days to Cover

Recent HCW Biologics Inc News

Why Is HCW Biologics Stock Surging 102% Overnight?

HCW Biologics' stock jumped 102.72% to $6.73 after the company revealed the successful development of second-generation T-cell engagers for solid tumors.

Mohd Haider

HCW Biologics Shares Soar On Breakthrough Second-Generation Cancer Immunotherapy

HCW Biologics Inc. (NASDAQ: HCWB) shares were up Monday after the company announced a breakthrough in developing second-generation pembrolizumab-based immunotherapies for solid tumors.

Vaishali Prayag

HCW Biologics' Shares Surge After Unveiling Next-Gen Cancer Immunotherapy Platform

HCW Biologics shares jump after unveiling TRBC-based fusion therapy that enhances immune response and shows strong preclinical results in solid tumors.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-13.39M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

10.67M

Free Cash Flow (TTM)

-13.39M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-2.72M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$7.58M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

15.62

PB Ratio (TTM)

0.98

Earnings Yield % (TTM)

-2631.84%

Earnings Yield % (FWD)

-252.54%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.41

Company Debt

Total Debt

$6.81M

LT Debt

LT Debt Issuance (TTM)

$150.00K

LT Debt Repayment (TTM)

-$127.62K

Total Cash

$1.95M

Debt to Equity

2.46

Issuance of Debt (TTM)

$22.38K

Repayment of Debt (TTM)

-$127.62K

Key Statistics

Open

$0.41

Volume / Avg.

108.25K / 8.25M

Day Range

- - -

52 Wk Range

0.25 - 17.80

Market Cap

$1.44M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

3.61%

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy HCW Biologics (HCWB) stock?

You can purchase shares of HCW Biologics (NASDAQ:HCWB) through any online brokerage.

View our list of the best stock brokerages

Who are HCW Biologics (HCWB) competitors?

Other companies in HCW Biologics’s space includes: Geovax Labs Inc (NASDAQ:GOVX), Genprex Inc (NASDAQ:GNPX), Dermata Therapeutics Inc (NASDAQ:DRMAW), Medicus Pharma Ltd (NASDAQ:MDCXW) and Psyence Biomedical Ltd (NASDAQ:PBM).

What is the forecast, or price target, for HCW Biologics (HCWB) stock?

HCW Biologics has a consensus price target of $17.67.

What is the current price for HCW Biologics (HCWB)?

The stock price for HCW Biologics (NASDAQ: HCWB) is $0.4087 last updated April 16, 2026 at 8:28 AM EDT.

Does HCW Biologics (HCWB) pay a dividend?

There are no upcoming dividends for HCW Biologics.

When is HCW Biologics (NASDAQ:HCWB) reporting earnings?

HCW Biologics does not have any upcoming earnings scheduled.

Is HCW Biologics (HCWB) going to split?

There is no upcoming split for HCW Biologics.

What sector and industry does HCW Biologics (HCWB) operate in?

HCW Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Dermata Therapeutics Inc

Psyence Biomedical Ltd

Key Statistics

Open

$0.41

Volume / Avg.

108.25K / 8.25M

Day Range

- - -

52 Wk Range

0.25 - 17.80

Market Cap

$1.44M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

3.61%

Days to Cover

Recent HCW Biologics Inc News

Why Is HCW Biologics Stock Surging 102% Overnight?

HCW Biologics' stock jumped 102.72% to $6.73 after the company revealed the successful development of second-generation T-cell engagers for solid tumors.

Mohd Haider

HCW Biologics Shares Soar On Breakthrough Second-Generation Cancer Immunotherapy

HCW Biologics Inc. (NASDAQ: HCWB) shares were up Monday after the company announced a breakthrough in developing second-generation pembrolizumab-based immunotherapies for solid tumors.

Vaishali Prayag

HCW Biologics' Shares Surge After Unveiling Next-Gen Cancer Immunotherapy Platform

HCW Biologics shares jump after unveiling TRBC-based fusion therapy that enhances immune response and shows strong preclinical results in solid tumors.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-13.39M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

10.67M

Free Cash Flow (TTM)

-13.39M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-2.72M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$7.58M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

15.62

PB Ratio (TTM)

0.98

Earnings Yield % (TTM)

-2631.84%

Earnings Yield % (FWD)

-252.54%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.41

Company Debt

Total Debt

$6.81M

LT Debt

LT Debt Issuance (TTM)

$150.00K

LT Debt Repayment (TTM)

-$127.62K

Total Cash

$1.95M

Debt to Equity

2.46

Issuance of Debt (TTM)

$22.38K

Repayment of Debt (TTM)

-$127.62K

Key Statistics

Open

$0.41

Volume / Avg.

108.25K / 8.25M

Day Range

- - -

52 Wk Range

0.25 - 17.80

Market Cap

$1.44M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

3.61%

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry